These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results Terminated 2006-005678-36 Oral alendronate for osteoporosis treatment in non-walking children with cerebral palsy bad-data
Ongoing, reported early 2007-005437-11 Arthrose érosive des doigts : traitement par méthotrexate versus placebo- évaluation de l’action clinique et structurale (IRM dédiée)- Etude ADEM not-yet-due
Ongoing 2008-000239-17 Use of MEOPA by elderly with dementia not-yet-due
Reported results 2008-003945-10 ACTION OF THE AMANTADINE ON POST STROKE APHASIC PATIENTS LANGUAGE AND COMMUNICATION 2014-04-04 due-trials
Reported results 2008-004705-34 PROTOCOLE D’ANALGESIE POST OPERATOIRE PAR INFILTRATION CONTINUE DE ROPIVACAINE DANS LES ARTHRODESES DU RACHIS LOMBAIRE 2010-12-17 due-trials
Ongoing 2009-012750-21 Traitement des épidermolyses bulleuses dystrophiques héréditaires par l’épigallocatéchine-3-gallate oral (Polyphenon E®) not-yet-due
Ongoing, reported early 2009-013656-77 Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin. not-yet-due
No trial status on register, and reported results 2010-022440-20 Traitements of angioma plans of the child by laser to pulsed colouring agent and Timolol (Néogel 0,1%). bad-data
No trial status on register, and reported results 2010-024428-10 Traitement des épidermolyses bulleuses simples de type Dowling Maera par l'érythromicine orale bad-data
No trial status on register 2012-004546-15 Assessment of incidence of adverse events in a naive pediatric population treated with an antipsychotic drug over 12 months follow-up EVALUATION DE L’INCIDENCE DES EVENEMENTS INDESIRABLES EN POPULA... bad-data
Not reported 2014-003273-42 Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive Comparaison d’un traitement diurétique au remplissage vas... 2020-04-09 due-trials
Not reported 2015-001614-94 Hepatoprotective role of SMOFlipid® used in short-term parenteral nutrition in an Onco-Hematology Pediatric Population, pilot study Etude pilote du rôle hépatoprotecteur des SMOFlipid® en nutrition... 2016-10-18 due-trials
Not reported 2015-002298-39 A national, multi-center study to evaluate the safety of long term treatment with teriflunomide 14 mg once daily in patients with a first clinical episode suggestive of multiple sclerosis in a long-te... 2020-08-31 due-trials
Reported results 2015-003944-38 Treatment of the oral aphtose récidivante and idiopathique of the adult by probiotics Double-blind randomized interventional study versus placebo 2019-05-02 due-trials
Ongoing 2017-004608-22 Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinoma Study "PICABAS" Etude ouverte, prospective... not-yet-due
Not reported 2018-001371-20 Study of the role of local treatments on the modulation of the microbiome in psoriatic skin Etude du rôle des traitements locaux sur la modulation du microbiome dans la peau psoriasique 2019-03-07 due-trials
Ongoing 2018-002476-40 Personalized Medicine for Membranous Nephropathy PMMN not-yet-due
Ongoing 2018-004072-35 Study of the value of early treatment with an endothelin inhibitor (Bosentan) in patients with sudden blindness secondary to giant cell arteritis Etude de l’intérêt d’un traitement précoce par un... not-yet-due
Ongoing 2018-004300-19 Target-controled infusion with propofol in the Emergency Department : a prospective study on 50 adult patients Sédation Intraveineuse à Objectif de Concentration (SIVOC) au propofol à l’accueil des... not-yet-due
Ongoing 2020-001542-19 A 12-Week Multicentre, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Placebo in Patients > 6 years of age with EB simplex generalized severe not-yet-due
Ongoing 2020-002912-34 Treatment of bullous pemphigoid with avdoralimab (IPH5401), an anti-C5aR1 monoclonal antibody not-yet-due
Ongoing 2020-003169-20 Efficacy of dalbavancin during osteo-articular infections associated with hip and knee prostheses Efficacité de la dalbavancine au cours des infections ostéo-articulaires associées aux prothèses (I... not-yet-due